key: cord-0926348-5zcivdm4
authors: Barrett, Eileen; Apodaca, Krystle
title: Response to "Alcohol and COVID-19: How Do We Respond to This Growing Public Health Crisis?”
date: 2021-04-26
journal: J Gen Intern Med
DOI: 10.1007/s11606-021-06824-3
sha: fd0e1e7fc29e356554dd93e0ab29f1bf40551d20
doc_id: 926348
cord_uid: 5zcivdm4

nan

We read with interest "Alcohol and COVID-19: How Do We Respond to This Growing Public Health Crisis?" noting particularly how COVID-19 is distinct from other global tragedies. 1 We appreciate the authors' recognition of the persistent barriers in primary care to treating patients with alcohol use disorders, and careful description of how to improve treatment. Additionally, it is not uncommon for a hospitalist to be the first clinician the patient has contact with, especially if the patient is not established with primary care. This puts hospitalists in a unique position to have an impact on treating patients with alcohol use disorders. As hospitalists engaged in improving the care and clinical experience of people with alcohol use disorders, we are writing to implore inpatient clinicians to also develop processes and systems to connect patients with treatment.

A review published in 2018 examined data on medications for alcohol use disorder and concluded that naltrexone, acamprosate, and topiramate are the most effective in reducing alcohol use, but are notably underutilized. 2 Additional support for prescribing naltrexone was demonstrated earlier this year in a real-world study finding that this medication, either alone or in combination with disulfiram or acamprosate, was associated with lower risk of hospitalization due to any cause, including alcohol-related. 3 Hospitalists can have an important role in promoting the use of medications for patients with alcohol use disorders. In 2015, an intervention to identify patients who may benefit from alcohol use disorder treatment increased prescriptions of naltrexone while decreasing readmissions and emergency department visits. 4 Furthermore, a 2018 study evaluating the effects of clinician education on naltrexone and the adoption of algorithms for evaluating patients for naltrexone resulted in subgroups of patients having reduced emergency department visits and rehospitalizations. 5 We believe hospital medicine teams should take advantage of opportunities to improve care of patients with alcohol use disorders. Hospitalization is an opportune time for a patient to receive screening, counseling, and treatment of alcohol use disorders. Hospitalists are well-positioned to promote solutions to public health crises, and have a history of doing so-particularly among patients who are not regularly seen in primary care. Initiating treatment for alcohol use disorders while inpatient or at the time of discharge, and providing warm hand-offs to colleagues in primary care, is the next step in improving care among this vulnerable population of patients.

Alcohol and COVID-19: How Do We Respond to This Growing Public Health Crisis

Real-world Effectiveness of Pharmacological Treatments of Alcohol Use Disorders in a Swedish Nationwide Cohort of 125,556 patients

An Inpatient Treatment and Discharge Planning Protocol for Alcohol Dependence: Efficacy in Reducing 30-Day Readmissions and Emergency Department Visits

Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal